Delivery Order SPE2DX22D0010-SPE2D825FJS57
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,070.28 to AmerisourceBergen Drug Corp for Nucynta Tabs 100mg, a prescription pain management medication. This competitively awarded, firm fixed-price contract was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nucynta 75 mg tablets (100 count) with a ceiling value of $2,451.24. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,843.64 with firm fixed pricing and is scheduled for completion by September 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a pharmaceutical pain management product, with a contract value of $4,001.46. This non-competitive delivery order, issued on August 12, 2025, utilizes firm fixed pricing and is set to conclude on August 13, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,240.67 to AmerisourceBergen Drug Corp for the supply of Nucynta Tabs 100mg, a pain management pharmaceutical product. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. The delivery order is scheduled for completion by July 31, 2025, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,982.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta Tabs 50mg, a prescription pain management pharmaceutical. This non-set-aside, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Nucynta ER Tabs 100mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at $9,992.08, represents a competitive award with no set-aside designation and is scheduled for completion by July 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,148.57 to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100-count units) on September 18, 2025, with a ceiling value of $1,496.48 and a firm fixed-price structure. This delivery order represents a non-competitive set-aside and is performed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Nucynta 50 mg tablets (100 units) with a ceiling value of $1,225.04. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by September 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJS57Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,375.14 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. As a child contract under this substantial IDC, the Nucynta Tabs delivery order represents one of numerous pharmaceutical procurement transactions fulfilling critical medical supply needs for Department of Defense and other federal health agencies. AmerisourceBergen's status as a preferred pharmaceutical vendor for federal procurement reflects the company's demonstrated capability to meet stringent medical supply requirements through competitive federal contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 9/29/25 |